🇺🇸 FDA
Patent

US 8394764

Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use

granted A61KA61K38/1709A61K47/60

Quick answer

US patent 8394764 (Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/1709, A61K47/60, A61K47/61, A61K47/62